The latest price target for Mesa Laboratories (NASDAQ:MLAB) was reported by Wells Fargo on August 27, 2024. The analyst firm set a price target for $120.00 expecting MLAB to fall to within 12 months (a possible -6.67% downside). 5 analyst firms have reported ratings in the last year.

The latest analyst rating for Mesa Laboratories (NASDAQ:MLAB) was provided by Wells Fargo, and Mesa Laboratories initiated their underweight rating.

The last upgrade for Mesa Laboratories Inc happened on January 4, 2024 when Evercore ISI Group raised their price target to $125. Evercore ISI Group previously had an in-line for Mesa Laboratories Inc.

There is no last downgrade for Mesa Laboratories.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mesa Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mesa Laboratories was filed on August 27, 2024 so you should expect the next rating to be made available sometime around August 27, 2025.

While ratings are subjective and will change, the latest Mesa Laboratories (MLAB) rating was a initiated with a price target of $0.00 to $120.00. The current price Mesa Laboratories (MLAB) is trading at is $128.57, which is out of the analyst’s predicted range.